Epilepsy is a disorder of the brain characterized by repeated seizures. A seizure is usually defined as a sudden alteration of behavior due to a temporary change in the electrical functioning of the brain. Normally, the brain continuously generates tiny electrical impulses in an orderly pattern. These impulses travel along neurons - the network of nerve cells in the brain - and throughout the whole body via chemical messengers called neurotransmitters. In epilepsy, the brain's electrical rhythms tend to become imbalanced, resulting in recurrent seizures. Moreover, in patients with seizures, the normal electrical pattern is disrupted by sudden and synchronized bursts of electrical energy that may briefly affect their consciousness, movements, or sensations.
This report contains market size and forecasts of Epileptic Seizures Treatment in Global, including the following market information:
Global Epileptic Seizures Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Epileptic Seizures Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Treatment Practices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epileptic Seizures Treatment include Bausch Health Companies, Inc., GlaxoSmithKline plc., UCB S.A., Pfizer, Inc., Apotex, Inc., Alexza Pharmaceuticals, Inc., Neurelis, Inc. and Veriton Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epileptic Seizures Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epileptic Seizures Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Epileptic Seizures Treatment Market Segment Percentages, by Type, 2021 (%)
Treatment Practices
Emerging Drugs
Individual Therapies
Global Epileptic Seizures Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Epileptic Seizures Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Epileptic Seizures Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Epileptic Seizures Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epileptic Seizures Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Epileptic Seizures Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health Companies, Inc.
GlaxoSmithKline plc.
UCB S.A.
Pfizer, Inc.
Apotex, Inc.
Alexza Pharmaceuticals, Inc.
Neurelis, Inc.
Veriton Pharma